Che Bian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Che Bian has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Huiwen Ren
Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, China
7 shared publications Jia Li
Department of Endocrinology and Metabolism, The Fourth Affiliated Hospital of China Medical University, Shenyang, China
5 shared publicationsJing Gao
Department of Cardiology, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China
5 shared publicationsRuijing Zhang
Department of Nephrology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China
4 shared publicationsYuxia Wang
Department of Endocrinology and Metabolism, The Fourth Affiliated Hospital of China Medical University, Shenyang, China
4 shared publicationsHaibo Zhang
College of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China
3 shared publications
Latest Publications
- Open Access
- 3 December 2024
- Published by Elsevier in Pharmacological Research
- Vol. 210, 107532
A novel approach to explore metabolic diseases: Neddylation
- 3 December 2024
- Published by Elsevier in Pharmacological Research
- Vol. 210, 107532
Open AccessA novel approach to explore metabolic diseases: Neddylation
- Open Access
- 6 September 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 179, 117403
Ecnomotopic olfactory receptors in metabolic regulation
- 6 September 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 179, 117403
Open AccessEcnomotopic olfactory receptors in metabolic regulation
- 7 June 2023
- Published by Springer Nature in Apoptosis
- Vol. 28 (7-8) , 977-996
Endoplasmic reticulum stress in diabetic kidney disease: adaptation and apoptosis after three UPR pathways
Diabetes kidney disease (DKD) is one of the common chronic microvascular complications of diabetes, which has become the most important cause of modern chronic kidney disease beyond chronic glomerulonephritis. The endoplasmic reticulum is one of the largest organelles, and endoplasmic reticulum stress (ERS) is the basic mechanism of metabolic disorder in all organs and tissues. Under the stimulation of stress-induced factors, the endoplasmic reticulum, as a trophic receptor, regulates adaptive and apoptotic ERS through molecular chaperones and three unfolded protein reaction (UPR) pathways, thereby regulating diabetic renal damage. Therefore, three pathway factors have different expressions in different sections of renal tissues. This study deeply discussed the specific reagents, animals, cells, and clinical models related to ERS in DKD, and reviewed ERS-related three pathways on DKD with glomerular filtration membrane, renal tubular reabsorption, and other pathological lesions of different renal tissues, as well as the molecular biological mechanisms related to the balance of adaption and apoptosis by searching and sorting out MeSH subject words from PubMed database.
- 7 June 2023
- Published by Springer Nature in Apoptosis
- Vol. 28 (7-8) , 977-996
Endoplasmic reticulum stress in diabetic kidney disease: adaptation and apoptosis after three UPR pathways
Diabetes kidney disease (DKD) is one of the common chronic microvascular complications of diabetes, which has become the most important cause of modern chronic kidney disease beyond chronic glomerulonephritis. The endoplasmic reticulum is one of the largest organelles, and endoplasmic reticulum stress (ERS) is the basic mechanism of metabolic disorder in all organs and tissues. Under the stimulation of stress-induced factors, the endoplasmic reticulum, as a trophic receptor, regulates adaptive and apoptotic ERS through molecular chaperones and three unfolded protein reaction (UPR) pathways, thereby regulating diabetic renal damage. Therefore, three pathway factors have different expressions in different sections of renal tissues. This study deeply discussed the specific reagents, animals, cells, and clinical models related to ERS in DKD, and reviewed ERS-related three pathways on DKD with glomerular filtration membrane, renal tubular reabsorption, and other pathological lesions of different renal tissues, as well as the molecular biological mechanisms related to the balance of adaption and apoptosis by searching and sorting out MeSH subject words from PubMed database.
- Open Access
- 14 June 2022
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 901066
Sirtuin Family and Diabetic Kidney Disease
Diabetes mellitus (DM) is gradually attacking the health and life of people all over the world. Diabetic kidney disease (DKD) is one of the most common chronic microvascular complications of DM, whose mechanism is complex and still lacks research. Sirtuin family is a class III histone deacetylase with highly conserved NAD+ binding domain and catalytic functional domain, while different N-terminal and C-terminal structures enable them to bind different deacetylated substrates to participate in the cellular NAD+ metabolism. The kidney is an organ rich in NAD+ and database exploration of literature shows that the Sirtuin family has different expression localization in renal, cellular, and subcellular structures. With the progress of modern technology, a variety of animal models and reagents for the Sirtuin family and DKD emerged. Machine learning in the literature shows that the Sirtuin family can regulate pathophysiological injury mainly in the glomerular filtration membrane, renal tubular absorption, and immune inflammation through various mechanisms such as epigenetics, multiple signaling pathways, and mitochondrial function. These mechanisms are the key nodes participating in DKD. Thus, it is of great significance for target therapy to study biological functions of the Sirtuin family and DKD regulation mechanism in-depth.
- 14 June 2022
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 901066
Open AccessSirtuin Family and Diabetic Kidney Disease
Diabetes mellitus (DM) is gradually attacking the health and life of people all over the world. Diabetic kidney disease (DKD) is one of the most common chronic microvascular complications of DM, whose mechanism is complex and still lacks research. Sirtuin family is a class III histone deacetylase with highly conserved NAD+ binding domain and catalytic functional domain, while different N-terminal and C-terminal structures enable them to bind different deacetylated substrates to participate in the cellular NAD+ metabolism. The kidney is an organ rich in NAD+ and database exploration of literature shows that the Sirtuin family has different expression localization in renal, cellular, and subcellular structures. With the progress of modern technology, a variety of animal models and reagents for the Sirtuin family and DKD emerged. Machine learning in the literature shows that the Sirtuin family can regulate pathophysiological injury mainly in the glomerular filtration membrane, renal tubular absorption, and immune inflammation through various mechanisms such as epigenetics, multiple signaling pathways, and mitochondrial function. These mechanisms are the key nodes participating in DKD. Thus, it is of great significance for target therapy to study biological functions of the Sirtuin family and DKD regulation mechanism in-depth.
- 1 May 2022
- Published by Elsevier in Laboratory Investigation
- Vol. 102 (5) , 474-484
SIRT6 regulates SREBP1c-induced glucolipid metabolism in liver and pancreas via the AMPKα-mTORC1 pathway
- 1 May 2022
- Published by Elsevier in Laboratory Investigation
- Vol. 102 (5) , 474-484
SIRT6 regulates SREBP1c-induced glucolipid metabolism in liver and pancreas via the AMPKα-mTORC1 pathway
- 11 February 2022
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 547, 111597
Sirtuin 6 affects glucose reabsorption and gluconeogenesis in type 1 diabetes via FoxO1
- 11 February 2022
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 547, 111597
Sirtuin 6 affects glucose reabsorption and gluconeogenesis in type 1 diabetes via FoxO1
- Open Access
- 27 January 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 7502632
miR‐154‐5p Affects the TGFβ1/Smad3 Pathway on the Fibrosis of Diabetic Kidney Disease via Binding E3 Ubiquitin Ligase Smurf1
Aim. The study is aimed at verifying miR‐154‐5p and Smurf1 combination in glomerular mesangial cells regulating TGFβ1/Smad3 pathway‐related protein ubiquitination in the model of diabetic rats renal tissues, primary mesangial cells, and cell lines. Methods. The diabetic SD rat model and high‐glucose‐cultured primary mesangial cells and cell lines were established. miR‐154‐5p mimic and inhibitor, Smurf1 siRNA, and TGF β 1/Smad3 inhibitor (SB431542) were pretreated to make the TGFβ1/Smad3 pathway and ubiquitin changes. Fluorescence in situ hybridization was used for the miR‐154‐5p renal localization; molecular biological detection was adopted for cell proliferation, renal function, urine protein, and pathway proteins. After bioinformatics predicted binding sites, luciferase and Co‐IP were used to detect miRNA and protein binding. Results. miR‐154‐5p was significantly increased and mainly concentrated in the glomerular of renal cortex in well‐established diabetic rat renal tissues. Rno‐miR‐154‐5p combined Rno‐Smurf1 3 ′ UTR, while Smurf1 combined Smad3 directly. Meanwhile, miR‐154‐5p regulates TGFβ1/Smad3‐mediated cell proliferation via Smurf1 ubiquitination. Conclusion. miR‐154‐5p regulates the TGFβ1/Smads pathway through Smurf1 ubiquitination and promotes the fibrosis process of diabetic kidney disease.
- 27 January 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 7502632
Open AccessmiR‐154‐5p Affects the TGFβ1/Smad3 Pathway on the Fibrosis of Diabetic Kidney Disease via Binding E3 Ubiquitin Ligase Smurf1
Aim. The study is aimed at verifying miR‐154‐5p and Smurf1 combination in glomerular mesangial cells regulating TGFβ1/Smad3 pathway‐related protein ubiquitination in the model of diabetic rats renal tissues, primary mesangial cells, and cell lines. Methods. The diabetic SD rat model and high‐glucose‐cultured primary mesangial cells and cell lines were established. miR‐154‐5p mimic and inhibitor, Smurf1 siRNA, and TGF β 1/Smad3 inhibitor (SB431542) were pretreated to make the TGFβ1/Smad3 pathway and ubiquitin changes. Fluorescence in situ hybridization was used for the miR‐154‐5p renal localization; molecular biological detection was adopted for cell proliferation, renal function, urine protein, and pathway proteins. After bioinformatics predicted binding sites, luciferase and Co‐IP were used to detect miRNA and protein binding. Results. miR‐154‐5p was significantly increased and mainly concentrated in the glomerular of renal cortex in well‐established diabetic rat renal tissues. Rno‐miR‐154‐5p combined Rno‐Smurf1 3 ′ UTR, while Smurf1 combined Smad3 directly. Meanwhile, miR‐154‐5p regulates TGFβ1/Smad3‐mediated cell proliferation via Smurf1 ubiquitination. Conclusion. miR‐154‐5p regulates the TGFβ1/Smads pathway through Smurf1 ubiquitination and promotes the fibrosis process of diabetic kidney disease.
- 1 September 2021
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 179, 109034
Endogenous fructose is correlated with urinary albumin creatinine ratios and uric acid in type 2 diabetes mellitus
- 1 September 2021
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 179, 109034
Endogenous fructose is correlated with urinary albumin creatinine ratios and uric acid in type 2 diabetes mellitus
- Open Access
- 2 July 2021
- Published by Wiley in Journal of Oncology
- Vol. 2021, 1-9
Hsa-miR-330-5p Aggravates Thyroid Carcinoma via Targeting FOXE1
Background. Thyroid carcinoma (TC) is one of the frequent endocrine malignancies, and growing evidence suggests that aberrant microRNA (miRNA) expression contributes to TC development and progression. Nevertheless, the function of miR-330-5p in the progression of TC remains unknown. Methods. The expression levels of miR-330-5 in patients with thyroid carcinoma and healthy controls were detected, and their potential diagnostic and prognostic values were analyzed. Results. In this study, we firstly found that miR-330-5p expression was markedly upregulated in TC tissue and cell lines. Functionally, the downregulation of miR-330-5p suppressed TCcell proliferation, migration, and invasion. Further studies revealed that miR-330-5p negatively regulated the expression of forkhead box E1 (FOXE1). More importantly, the results of rescue experiments suggested that FOXE1 overexpression reduced the positive effects of miR-330-5p overexpression in TPC-1 and K-1 cells. Conclusions. This work revealed that miR-330-5p facilitated the TC progression through targeting FOXE1, which may offer novel therapeutic options for TC.
- 2 July 2021
- Published by Wiley in Journal of Oncology
- Vol. 2021, 1-9
Open AccessHsa-miR-330-5p Aggravates Thyroid Carcinoma via Targeting FOXE1
Background. Thyroid carcinoma (TC) is one of the frequent endocrine malignancies, and growing evidence suggests that aberrant microRNA (miRNA) expression contributes to TC development and progression. Nevertheless, the function of miR-330-5p in the progression of TC remains unknown. Methods. The expression levels of miR-330-5 in patients with thyroid carcinoma and healthy controls were detected, and their potential diagnostic and prognostic values were analyzed. Results. In this study, we firstly found that miR-330-5p expression was markedly upregulated in TC tissue and cell lines. Functionally, the downregulation of miR-330-5p suppressed TCcell proliferation, migration, and invasion. Further studies revealed that miR-330-5p negatively regulated the expression of forkhead box E1 (FOXE1). More importantly, the results of rescue experiments suggested that FOXE1 overexpression reduced the positive effects of miR-330-5p overexpression in TPC-1 and K-1 cells. Conclusions. This work revealed that miR-330-5p facilitated the TC progression through targeting FOXE1, which may offer novel therapeutic options for TC.
- 20 June 2021
- Published by Springer Nature in Acta Diabetologica
- Vol. 58 (11) , 1551-1562
Association of SIRT6 circulating levels with urinary and glycometabolic markers in pre-diabetes and diabetes
Aim The study is aimed to detect the expression of serum Sirtuin 6 (SIRT6) with different severities and urinary albumin creatinine ratios (UACR) in type 2 diabetes mellitus (T2DM) patients, thus exploring the association of SIRT6 together with glycolipid metabolism and urinary protein in the cross-sectional study. Methods T2DM patients (313 cases), pre-diabetic patients (102 cases), and healthy volunteers (100 cases) were selected. T2DM patients were divided into the normal albuminuria (103 cases, UACR < 30 mg/g), micro-albuminuria (106 cases, UACR 30–300 mg/g), and large amount of albuminuria group (104 cases, UACR > 300 mg/g) based on different UACR levels. The medical history was asked, biochemical indicators were detected, hematuria samples were taken, serum SIRT6 levels were detected, and detailed statistical analysis was conducted. Results FPG, 2 h-PG, HOMA-IR, HbA1c, and LDL-C increased, while ISI and HDL-C decreased with the aggravation of diabetic status (P < 0.05). HbA1c, UACR, TNFα, HIF1α, and SIRT6 increased with UACR in T2DM patients (P < 0.05). Correlation analysis demonstrated that SIRT6 was significantly positively correlated with glycolipid metabolism in the whole samples, and correlated with UACR, TNFα, and HIF1α in T2DM patients (P < 0.05). Ridge regression analysis showed that SIRT6 was a risk factor for both glycolipid metabolism and urinary protein (P < 0.05). Conclusion SIRT6 increases with biomarkers in glycolipid metabolism and urinary protein in different severities of diabetes and UACR, which is expected to be a potential biomarker for early prediction and diagnosis related to glycolipid metabolism disorders and related nephropathy. Trial number: ChiCTR2000039808.
- 20 June 2021
- Published by Springer Nature in Acta Diabetologica
- Vol. 58 (11) , 1551-1562
Association of SIRT6 circulating levels with urinary and glycometabolic markers in pre-diabetes and diabetes
Aim The study is aimed to detect the expression of serum Sirtuin 6 (SIRT6) with different severities and urinary albumin creatinine ratios (UACR) in type 2 diabetes mellitus (T2DM) patients, thus exploring the association of SIRT6 together with glycolipid metabolism and urinary protein in the cross-sectional study. Methods T2DM patients (313 cases), pre-diabetic patients (102 cases), and healthy volunteers (100 cases) were selected. T2DM patients were divided into the normal albuminuria (103 cases, UACR < 30 mg/g), micro-albuminuria (106 cases, UACR 30–300 mg/g), and large amount of albuminuria group (104 cases, UACR > 300 mg/g) based on different UACR levels. The medical history was asked, biochemical indicators were detected, hematuria samples were taken, serum SIRT6 levels were detected, and detailed statistical analysis was conducted. Results FPG, 2 h-PG, HOMA-IR, HbA1c, and LDL-C increased, while ISI and HDL-C decreased with the aggravation of diabetic status (P < 0.05). HbA1c, UACR, TNFα, HIF1α, and SIRT6 increased with UACR in T2DM patients (P < 0.05). Correlation analysis demonstrated that SIRT6 was significantly positively correlated with glycolipid metabolism in the whole samples, and correlated with UACR, TNFα, and HIF1α in T2DM patients (P < 0.05). Ridge regression analysis showed that SIRT6 was a risk factor for both glycolipid metabolism and urinary protein (P < 0.05). Conclusion SIRT6 increases with biomarkers in glycolipid metabolism and urinary protein in different severities of diabetes and UACR, which is expected to be a potential biomarker for early prediction and diagnosis related to glycolipid metabolism disorders and related nephropathy. Trial number: ChiCTR2000039808.